Stefanie Kretschmer
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Innate immune signaling as a potential pathomechanistic biomarker for distinct subtypes in amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: June 15, 2026
Discordant phenotype caused by TREX1 variant in siblings with Aicardi-Goutières syndrome.
Journal: Pediatric rheumatology online journal
Published: August 06, 2025
RIG-I Mediated Neuron-Specific IFN Type 1 Signaling in FUS-ALS Induces Neurodegeneration and Offers New Biomarker-Driven Individualized Treatment Options for (FUS-)ALS.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 18, 2024
Structural basis for OAS2 regulation and its antiviral function.
Journal: Molecular cell
Published: October 11, 2024
C-terminal variants in CDC42 drive type I interferon-dependent autoinflammation in NOCARH syndrome reversible by ruxolitinib.
Journal: Clinical immunology (Orlando, Fla.)
Published: June 21, 2023
Tissue factor binds to and inhibits interferon-α receptor 1 signaling.
Journal: Immunity
Published: August 14, 2022
Generation of induced pluripotent stem cell lines from three patients with Aicardi-Goutières syndrome type 5 due to biallelic SAMDH1 mutations.
Journal: Stem cell research
Published: August 10, 2022
Generation of induced pluripotent stem cell lines from two patients with Aicardi-Goutières syndrome type 1 due to biallelic TREX1 mutations.
Journal: Stem cell research
Published: March 01, 2022
SAMHD1 controls innate immunity by regulating condensation of immunogenic self RNA.
Journal: Molecular cell
Published: December 14, 2021
Therapeutic Approaches to Type I Interferonopathies.
Journal: Current rheumatology reports
Published: April 22, 2018
Type I interferon-mediated autoinflammation and autoimmunity.
Journal: Current opinion in immunology
Published: August 09, 2017
Last Updated: 09/26/2026